Physician profile

Scott A Berlin

Interventional Pain Medicine · Cleburne, TX

NPI 1952388753

$8,329.97

in general payments reported to CMS, 2019-2025

40 companies · $1,913 in 2025

The $1,913 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,369.68
Travel and Lodging$1,081.84
Gift$15.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $2,403.22 2019-2025 Eterna, Proclaim, Ionicrf
Medtronic, INC. $1,593.45 2021-2025 Intellis Adaptivestim, Inceptiv, Synchromedii
Genesys Orthopedics Systems, L.L.C. $1,204.75 2025 Sacroiliac Joint Fusion System
Medtronic USA, INC. $615.19 2019-2020
Boston Scientific Corporation $425.41 2020-2025 Intracept
Collegium Pharmaceutical, INC. $213.13 2019-2023 Xtampza
Saluda Medical Americas, INC. $173.16 2023-2025 Evoke, Evoke Scs
Mml US, INC. $147.81 2023 Reactiv8
Abbvie INC. $118.59 2021-2024
Arbor Pharmaceuticals, INC. $114.71 2019-2022
Tersera Therapeutics LLC $112.36 2019-2022
Nalu Medical, INC. $104.53 2020-2025 Nalu Neurostimulation System
Relievant Medsystems, INC. $102.25 2022-2023 Intracept
Si-Bone, INC. $89.58 2021-2025
Vgi Medical, LLC $88.68 2022
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Vertiflex, INC. $76.86 2019
Pfizer INC. $56.77 2019-2023
Vertex Pharmaceuticals Incorporated $56.40 2025
Teva Pharmaceuticals USA, INC. $55.22 2019-2020
Biohaven Pharmaceutical Holding Company LTD. $53.68 2022
Amgen INC. $47.01 2019
Novartis Pharmaceuticals Corporation $44.29 2019-2020
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $43.18 2023 Relistor
Allergan, INC. $41.74 2020
Spinal Simplicity, LLC $41.48 2024 Ha Minuteman G3-R
Ibsa Pharma INC. $36.64 2021-2023 Tirosint, Licart
Virtus Pharmaceuticals LLC $35.32 2021
Zimmer Biomet Holdings, INC. $32.83 2023 Gps III Platelet Concentration System
Biotronik Nro, INC. $28.87 2025 Prospera
Pacira Pharmaceuticals Incorporated $25.02 2023 Zilretta, Iovera
Averitas Pharma INC. $20.13 2025 Qutenza
Electronic Waveform Lab, INC. $19.86 2022
Scilex Pharmaceuticals INC. $17.19 2024
Vertos Medical, INC. $15.41 2024 Mild Device Kit
Azurity Pharmaceuticals, INC. $15.15 2025 Horizant
Bioventus LLC $14.96 2022
Epimed International, INC $13.83 2019
Horizon Therapeutics Plc $13.03 2021
Biodelivery Sciences International, INC. $11.45 2021
Spr Therapeutics, INC $6.83 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Scott A Berlin

$8,329.97

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,913 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/224905/scott-a-berlin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.